Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer. | Prostate | 2022 | 34672379 | PubTator, text mining | PubMed |
| Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas. | J Pathol Transl Med | 2022 | 34645111 | PubTator, text mining | PubMed |
| Extracellular vesicles: The key for precision medicine in glioblastoma. | Neuro Oncol | 2022 | 34581817 | PubTator, text mining | PubMed |
| Identification of hub genes in bladder cancer based on weighted gene co-expression network analysis from TCGA database. | Cancer Rep (Hoboken) | 2022 | 34541834 | PubTator, text mining | PubMed |
| Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration. | Curr Neuropharmacol | 2022 | 34414870 | PubTator, text mining | PubMed |
| Cell cycle on the crossroad of tumorigenesis and cancer therapy. | Trends Cell Biol | 2022 | 34304958 | PubTator, text mining | PubMed |
| Expansion of Fcγ Receptor IIIa-Positive Macrophages, Ficolin 1-Positive Monocyte-Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis. | Arthritis Rheumatol | 2022 | 34042322 | PubTator, text mining | PubMed |
| Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells. | Cell Biol Toxicol | 2022 | 33884520 | PubTator, text mining | PubMed |
| miR-362-3p suppresses sinonasal squamous cell carcinoma progression via directly targeting pituitary tumor-transforming gene 1. | J Recept Signal Transduct Res | 2022 | 33148101 | PubTator, text mining | PubMed |
| LncRNA SNHG6 Induces Epithelial-Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944. | Cancer Biother Radiopharm | 2022 | 32935999 | PubTator, text mining | PubMed |
| Exclusively heteronuclear NMR experiments for the investigation of intrinsically disordered proteins: focusing on proline residues. | Magn Reson (Gott) | 2021 | 37904768 | PubTator, text mining | PubMed |
| A specific selenium-chelating peptide isolated from the protein hydrolysate of Grifola frondosa. | RSC Adv | 2021 | 35423524 | PubTator, text mining | PubMed |
| Identification of Hub Genes in Pancreatic Ductal Adenocarcinoma Using Bioinformatics Analysis. | Iran J Public Health | 2021 | 35223598 | PubTator, text mining | PubMed |
| High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma. | Front Genet | 2021 | 35222518 | PubTator, text mining | PubMed |
| The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells. | Front Oncol | 2021 | 35145908 | PubTator, text mining | PubMed |
| Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis. | Transl Cancer Res | 2021 | 35116413 | PubTator, text mining | PubMed |
| Transcriptome analysis of the effect of a novel human serine protease inhibitor SPINK13 on gene expression in MHCC97-H cells. | Transl Cancer Res | 2021 | 35116303 | PubTator, text mining | PubMed |
| Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment. | Front Pharmacol | 2021 | 35095530 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate Cancer. | Front Oncol | 2021 | 35087757 | PubTator, text mining | PubMed |
| Targeting Aggressive Pituitary Adenomas at the Molecular Level-A Review. | J Clin Med | 2021 | 35011868 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=34